121 related articles for article (PubMed ID: 32932249)
1. Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis.
Tseng CH; Hsu YC; Ho HJ; Nguyen MH; Wu CY
Dig Dis; 2021; 39(3):266-274. PubMed ID: 32932249
[TBL] [Abstract][Full Text] [Related]
2. Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B.
Nguyen MH; Lim JK; Burak Ozbay A; Fraysse J; Liou I; Meyer N; Dusheiko G; Gordon SC
Hepatology; 2019 Mar; 69(3):959-973. PubMed ID: 30175482
[TBL] [Abstract][Full Text] [Related]
3. Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B.
Oh H; Jun DW; Lee IH; Ahn HJ; Kim BO; Jung S; Nguyen MH
Aliment Pharmacol Ther; 2020 Jul; 52(2):371-381. PubMed ID: 32542860
[TBL] [Abstract][Full Text] [Related]
4. Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia.
Sanai FM; Alghamdi H; Alswat KA; Babatin MA; Ismail MH; Alhamoudi WK; Alalwan AM; Dahlan Y; Alghamdi AS; Alfaleh FZ; Aljumah AA; Altraif IH; Albeladi K; Batwa F; Alshumrani W; Belhadi D; Genestier V; Abdo AA
Saudi J Gastroenterol; 2019; 25(3):194-200. PubMed ID: 30720002
[TBL] [Abstract][Full Text] [Related]
5. Real-world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan.
Chien HT; Su TH; Huang H; Chiang CL; Lin FJ
Liver Int; 2023 Nov; 43(11):2404-2414. PubMed ID: 37615056
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Healthcare Costs in the Aging Hepatitis B Population of Japan: A Nationwide Real-World Analysis.
Yotsuyanagi H; Kurosaki M; Yatsuhashi H; Lee IH; Ng A; Brooks-Rooney C; Nguyen MH
Dig Dis; 2022; 40(1):68-77. PubMed ID: 33721872
[TBL] [Abstract][Full Text] [Related]
7. An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory-Wide Study From 2000 to 2017.
Wong GL; Wong VW; Yuen BW; Tse YK; Luk HW; Yip TC; Hui VW; Liang LY; Lui GC; Chan HL
Hepatology; 2020 Feb; 71(2):444-455. PubMed ID: 31237366
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
[TBL] [Abstract][Full Text] [Related]
9. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
[TBL] [Abstract][Full Text] [Related]
11. [Research progress on the effect of common metabolism-related comorbidities on health outcomes and management strategies in patients with chronic hepatitis B].
Wang X; Xie JZ; Long ZC; Li JH; Hao YT; Jie YS; Gu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):319-324. PubMed ID: 38413075
[TBL] [Abstract][Full Text] [Related]
12. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.
Shyu YC; Huang TS; Chien CH; Yeh CT; Lin CL; Chien RN
J Viral Hepat; 2019 Jun; 26(6):718-726. PubMed ID: 30739359
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States.
Ogawa E; Yeo YH; Dang N; Le MH; Jeong D; Tran S; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2020 Apr; 3(4):e201844. PubMed ID: 32271388
[TBL] [Abstract][Full Text] [Related]
14. Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C.
Ogawa E; Chien N; Kam L; Yeo YH; Ji F; Huang DQ; Cheung R; Nguyen MH
JAMA Intern Med; 2023 Feb; 183(2):97-105. PubMed ID: 36508196
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of Entecavir and long-term mortality in chronic hepatitis B-related decompensated liver cirrhosis.
Hung TH; Tsai CC; Lee HF
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):694-699. PubMed ID: 30922728
[TBL] [Abstract][Full Text] [Related]
16. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
Hsu YC; Yip TC; Ho HJ; Wong VW; Huang YT; El-Serag HB; Lee TY; Wu MS; Lin JT; Wong GL; Wu CY
J Hepatol; 2018 Aug; 69(2):278-285. PubMed ID: 29551708
[TBL] [Abstract][Full Text] [Related]
17. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS).
Bixler D; Zhong Y; Ly KN; Moorman AC; Spradling PR; Teshale EH; Rupp LB; Gordon SC; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
Clin Infect Dis; 2019 Mar; 68(6):956-963. PubMed ID: 30060032
[TBL] [Abstract][Full Text] [Related]
18. The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis.
Kim LY; Yoo JJ; Chang Y; Jo H; Cho YY; Lee S; Lee DH; Jang JY;
J Korean Med Sci; 2024 Jan; 39(4):e22. PubMed ID: 38288536
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
Hamida ME; Raja SM; Seyoum Y; Elkhidir IM; Tekle F
BMC Gastroenterol; 2021 May; 21(1):198. PubMed ID: 33933017
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional retrospective analysis of clinical characteristics of chronic hepatitis B patients with oral antiviral treatment in eastern China.
Gu J; Yu G; Zhang X; Zhang S; Cai H; Ye C; Yang Y; Li D; Tong Z; Shen H; Chen H; Ding F; Lai X; Liu J; Xu M; Wu W
Virol J; 2021 Jan; 18(1):19. PubMed ID: 33441170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
